Evidence map›Paper›PMID 40534936›Full record

ArticleThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG2025

Eslicarbazepine Overdosing in a Teenager: Case Description and Management.

Maria Kavga, Jobst Rudolf, Foteini Mitsa, Nikolaos Raikos, Maria Fotoulaki, Paraskevi Panagopoulou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria Kavga4th Department of Pediatrics, Medical School (MK,MF,PP), Aristotle University of Thessaloniki, Papageorgiou General Hospital, Thessaloniki, Greece.
Jobst RudolfDepartment of Neurology (JR), Papageorgiou General Hospital, Thessaloniki, Greece.
Foteini MitsaLaboratory of Forensic Medicine and Toxicology (FT,NR), Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Nikolaos RaikosLaboratory of Forensic Medicine and Toxicology (FT,NR), Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Maria Fotoulaki4th Department of Pediatrics, Medical School (MK,MF,PP), Aristotle University of Thessaloniki, Papageorgiou General Hospital, Thessaloniki, Greece.
Paraskevi Panagopoulou4th Department of Pediatrics, Medical School (MK,MF,PP), Aristotle University of Thessaloniki, Papageorgiou General Hospital, Thessaloniki, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eslicarbazepine acetate has been recently licensed as an anti-epileptic medication to be used in adolescents. Data regarding dosing and overdosing are still limited in the literature. We describe a rare case of intentional eslicarbazepine overdosing in a previously healthy teenager who presented with neurological toxicity. Management of hyperhydration with diuretics, haloperidol, and midazolam proved to be helpful both in inducing rapid clearance through the kidneys and in managing symptoms of agitation, respectively.

Indexed as

adolescenceeslicarbazepine acetateneurological toxicityoverdosingpoisoning

Identifiers

PMID40534936
PMCPMC12172686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.